IMMUNIC Amendment: 683 Capital Exit Filing, 3.4% Stake

IMMUNIC, INC. files an Amendment No. 2 to a Schedule 13G/A noting an "exit filing" by certain reporting persons.

Rhea-AI Filing Summary

IMMUNIC, INC. files an Amendment No. 2 to a Schedule 13G/A noting an "exit filing" by certain reporting persons. The amendment states that, as of May 15, 2026, 683 Capital Partners, LP, 683 Capital Management, LLC and Ari Zweiman may be deemed to beneficially own 474,200 shares (including 229,200 exercisable warrants), representing 3.4% of the company's common stock. The filing cites 13,621,526 shares outstanding as of April 28, 2026 as the base for the percentage calculation and includes the verbatim comment that the Reporting Persons "no longer beneficially own more than five percent" of the issuer.

Insights

Institutional Ownership Analyst

Ownership drop below 5% via exit filing; holdings remain disclosed.

The filing records that the Reporting Persons may be deemed to beneficially own 474,200 shares, comprising 245,000 directly held shares and 229,200 exercisable warrants, equal to 3.4% on the stated outstanding base of 13,621,526 shares as of April 28, 2026.

Because the schedule is an exit amendment, it documents a reduction in reported stake below the 5% reporting threshold; cash‑flow treatment or specific transactions causing the reduction are not described in the excerpt.

Securities Compliance Specialist

Amendment frames a compliance update rather than a market action.

The document is structured to satisfy beneficial‑ownership disclosure requirements, including shared voting/dispositive power figures for the three Reporting Persons and an explanatory comment that this filing "constitutes an exit filing." The percentage calculation explicitly includes currently exercisable warrants.

Subsequent filings would be required if holdings cross the 5% threshold again; the excerpt does not state any planned trades or transfers.

Key Figures

Total deemed beneficial ownership: 474,200 shares Directly held shares: 245,000 shares Exercisable warrants: 229,200 warrants +2 more

5 metrics

Total deemed beneficial ownership 474,200 shares As of May 15, 2026 (includes exercisable warrants)

Directly held shares 245,000 shares Beneficially owned by 683 Capital Partners, LP as of May 15, 2026

Exercisable warrants 229,200 warrants Warrants exercisable and counted toward beneficial ownership as of May 15, 2026

Shares outstanding used for calc 13,621,526 shares Outstanding as of April 28, 2026 (base for percentage)

Percent of class 3.4% Reported beneficial ownership percentage including exercisable warrants

Key Terms

beneficially own, exercisable warrants, exit filing

3 terms

beneficially own regulatory

"This Amendment No. 2 constitutes an exit filing for the Reporting Persons"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

exercisable warrants financial

"warrants to purchase an additional 229,200 shares of Common Stock which are currently exercisable"

exit filing regulatory

"This Amendment No. 2 constitutes an exit filing for the Reporting Persons"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IMMUNIC (IMUX) Amendment No. 2 report about 683 Capital's stake?

It reports that 683 Capital and related persons may be deemed to beneficially own 474,200 shares, including 229,200 exercisable warrants, representing 3.4% of the class on the disclosed basis.

How is the 3.4% ownership percentage calculated in the filing?

The percentage is based on 13,621,526 shares outstanding as of April 28, 2026, plus 229,200 shares issuable upon exercise of currently exercisable warrants held by the Reporting Persons.

Which entities and individual are named as Reporting Persons in the Schedule 13G/A?

The filing names 683 Capital Management, LLC, 683 Capital Partners, LP, and Ari Zweiman as the Reporting Persons and provides their principal business address in New York.

Does the amendment explain how the stake fell below 5%?

No. The filing states it "constitutes an exit filing" because the Reporting Persons "no longer beneficially own more than five percent," but it does not describe the specific transactions or cash flows that produced the change.

Are warrants included in the beneficial‑ownership count in this filing?

Yes. The filing explicitly includes 229,200 currently exercisable warrants in the total deemed beneficial ownership of 474,200 shares as of May 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 10:48 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

IMMUNIC, INC.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

4525EP200

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 4525EP200

1

Names of Reporting Persons

683 CAPITAL MANAGEMENT, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 474,200.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 474,200.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

474,200.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.4 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.

SCHEDULE 13G

CUSIP Number(s): 4525EP200

1

Names of Reporting Persons

683 CAPITAL PARTNERS, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 474,200.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 474,200.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

474,200.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.4 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.

SCHEDULE 13G

CUSIP Number(s): 4525EP200

1

Names of Reporting Persons

Zweiman Ari

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 474,200.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 474,200.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

474,200.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.4 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: IMMUNIC, INC.
(b)	Address of issuer's principal executive offices: 1200 Avenue of the Americas, Suite 200, New York, New York 10036
Item 2.
(a)	Name of person filing: 683 Capital Management, LLC 683 Capital Partners, LP Ari Zweiman Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons."
(b)	Address or principal business office or, if none, residence: The principal business address for each of the Reporting Persons is 1700 Broadway, Suite 4200, New York, NY 10019.
(c)	Citizenship: 683 Capital Management, LLC - DELAWARE 683 Capital Partners, LP - DELAWARE Ari Zweiman - UNITED STATES
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 4525EP200
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of May 15, 2026, 683 Capital Partners, LP beneficially owned (i) 245,000 shares of Common Stock and (ii) warrants to purchase an additional 229,200 shares of Common Stock which are currently exercisable. 683 Capital Management, LLC, as the investment manager of 683 Capital Partners, LP, may be deemed to have beneficially owned (i) 245,000 shares of Common Stock and (ii) warrants to purchase an additional 229,200 shares of Common Stock beneficially owned by 683 Capital Partners, LP. Ari Zweiman, as the Managing Member of 683 Capital Management, LLC, may be deemed to have beneficially owned (i) 245,000 shares of Common Stock and (ii) warrants to purchase an additional 229,200 shares of Common Stock beneficially owned by 683 Capital Management, LLC. The following percentage is based on 13,621,526 shares of Common Stock outstanding as of April 28, 2026, as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on April 30, 2026, plus 229,200 shares of Common Stock issuable upon exercise of currently exercisable warrants held by the Reporting Persons. As of May 15, 2026, the Reporting Persons may be deemed to have beneficially owned a total of 474,200 shares of Common Stock, constituting approximately 3.4% of the outstanding shares of Common Stock.
(b)	Percent of class: 3.4%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9.
	(ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9.
	(iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
	(iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit 99.1 to Schedule 13G filed on August 8, 2025.
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

683 CAPITAL MANAGEMENT, LLC

Signature:	/s/ Ari Zweiman
Name/Title:	Ari Zweiman, Managing Member
Date:	05/15/2026

683 CAPITAL PARTNERS, LP

Signature:	/s/ Ari Zweiman
Name/Title:	Ari Zweiman, Authorized Person
Date:	05/15/2026

Zweiman Ari

Signature:	/s/ Ari Zweiman
Name/Title:	Ari Zweiman, Self
Date:	05/15/2026